Saquinavir: Difference between revisions
imported>David E. Volk mNo edit summary |
imported>Caesar Schinas m (Robot: Automated text replacement (-* {{CZMed +{{CZMed)) |
||
Line 24: | Line 24: | ||
== External links == | == External links == | ||
{{CZMed}} |
Revision as of 00:27, 4 June 2009
| |||||||
saquinavir | |||||||
| |||||||
Uses: | HIV | ||||||
Properties: | protease inhibitor | ||||||
Hazards: | see drug interactions | ||||||
|
Saquinavir, abbreviated SQV and sold under the trade names Fortovase®, Invirase® and ROC®, is a protease inhibitor used to treate HIV/AIDS. It is effective againsts HIV-1 and HIV-2. Saquinavir binds to the protease active site and inhibits its activity, thus preventing cleavage of the viral polyproteins resulting in immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs and due to their short half-life, often must be taken about every four hours.
Chemistry
Its IUPAC chemical name is (2S)-N-[(2S,3R)-4-[(3S)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide and its chemical formula is C38H5N6O5.
External links
The most up-to-date information about Saquinavir and other drugs can be found at the following sites.
- Saquinavir - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Saquinavir - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Saquinavir - Detailed information from DrugBank.